Next Article in Journal / Special Issue
Envelope Glycoprotein Trimers as HIV-1 Vaccine Immunogens
Previous Article in Journal
Evaluation of Different DNA Vaccines against Porcine Reproductive and Respiratory Syndrome (PRRS) in Pigs
Previous Article in Special Issue
An HIV Vaccine for South-East Asia—Opportunities and Challenges
Article Menu

Export Article

Open AccessReview
Vaccines 2013, 1(4), 481-496; doi:10.3390/vaccines1040481

Developing Combined HIV Vaccine Strategies for a Functional Cure

Vaccine and Gene Therapy Institute of Florida, Port Saint Lucie, Florida, FL 34987, USA
Author to whom correspondence should be addressed.
Received: 5 September 2013 / Revised: 8 October 2013 / Accepted: 12 October 2013 / Published: 28 October 2013
(This article belongs to the Special Issue HIV Vaccines)
View Full-Text   |   Download PDF [464 KB, uploaded 28 October 2013]


Increasing numbers of HIV-infected individuals have access to potent antiretroviral drugs that control viral replication and decrease the risk of transmission. However, there is no cure for HIV and new strategies have to be developed to reach an eradication of the virus or a natural control of viral replication in the absence of drugs (functional cure). Therapeutic vaccines against HIV have been evaluated in many trials over the last 20 years and important knowledge has been gained from these trials. However, the major obstacle to HIV eradication is the persistence of latent proviral reservoirs. Different molecules are currently tested in ART-treated subjects to reactivate these latent reservoirs. Such anti-latency agents should be combined with a vaccination regimen in order to control or eradicate reactivated latently-infected cells. New in vitro assays should also be developed to assess the success of tested therapeutic vaccines by measuring the immune-mediated killing of replication-competent HIV reservoir cells. This review provides an overview of the current strategies to combine HIV vaccines with anti-latency agents that could act as adjuvant on the vaccine-induced immune response as well as new tools to assess the efficacy of these approaches. View Full-Text
Keywords: HIV; therapeutic vaccine; CD8+ T cells; reactivation of viral reservoirs; combination therapy; functional cure HIV; therapeutic vaccine; CD8+ T cells; reactivation of viral reservoirs; combination therapy; functional cure
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Noto, A.; Trautmann, L. Developing Combined HIV Vaccine Strategies for a Functional Cure. Vaccines 2013, 1, 481-496.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top